Sotera Health Company
SHCHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframePart of the healthcare sector, Sotera Health Company (SHC) is listed under Diagnostics & Research. The $5.43B market capitalization puts SHC squarely in mid-cap range for its industry. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Market Cap
$5.43B
Beta
1.77
P/E (TTM)
33.39
P/E (Fwd)
17.70
EPS (TTM)
$0.57
EPS (Fwd)
$1.07
ROE
27.8%
ROA
8.6%
Cash
$357.0M
Total Debt
$2.27B
Free CF
$154.0M
52W Change
21.4%
Annual Financials
Cash vs Debt
Where SHC stands vs its 150-day and 200-day moving averages
As of the September 2, 2026 close, SHC finished 13.08% above its 150-day moving average ($16.52) and 11.46% above its 200-day moving average ($16.76). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SHC overbought or oversold?
At the September 2, 2026 close, SHC's RSI(14) was 46.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Sotera Health Company carries $2.27B in total debt against $357.0M in cash reserves — debt is roughly 6.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $154.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 27.8%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.6% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $1.00B to $1.16B.
A beta of 1.77 means SHC is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing SHC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.